These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 23092293)
41. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor. Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752 [TBL] [Abstract][Full Text] [Related]
42. The small molecule JIB-04 disrupts O Cascella B; Lee SG; Singh S; Jez JM; Mirica LM Chem Commun (Camb); 2017 Feb; 53(13):2174-2177. PubMed ID: 28144654 [TBL] [Abstract][Full Text] [Related]
43. Inhibitors of both the Bonnici J; Tumber A; Kawamura A; Schofield CJ Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685975 [TBL] [Abstract][Full Text] [Related]
44. Kinetic analysis of iron-dependent histone demethylases: α-ketoglutarate substrate inhibition and potential relevance to the regulation of histone demethylation in cancer cells. Cascella B; Mirica LM Biochemistry; 2012 Nov; 51(44):8699-701. PubMed ID: 23067339 [TBL] [Abstract][Full Text] [Related]
45. An high-throughput in vivo screening system to select H3K4-specific histone demethylase inhibitors. Mannironi C; Proietto M; Bufalieri F; Cundari E; Alagia A; Danovska S; Rinaldi T; Famiglini V; Coluccia A; La Regina G; Silvestri R; Negri R PLoS One; 2014; 9(1):e86002. PubMed ID: 24489688 [TBL] [Abstract][Full Text] [Related]
46. Mitochondrial control through nutritionally regulated global histone H3 lysine-4 demethylation. Soloveychik M; Xu M; Zaslaver O; Lee K; Narula A; Jiang R; Rosebrock AP; Caudy AA; Meneghini MD Sci Rep; 2016 Nov; 6():37942. PubMed ID: 27897198 [TBL] [Abstract][Full Text] [Related]
47. H3K9 demethylase KDM4E is an epigenetic regulator for bovine embryonic development and a defective factor for nuclear reprogramming. Liu X; Wang Y; Gao Y; Su J; Zhang J; Xing X; Zhou C; Yao K; An Q; Zhang Y Development; 2018 Feb; 145(4):. PubMed ID: 29453221 [TBL] [Abstract][Full Text] [Related]
48. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Xu W; Yang H; Liu Y; Yang Y; Wang P; Kim SH; Ito S; Yang C; Wang P; Xiao MT; Liu LX; Jiang WQ; Liu J; Zhang JY; Wang B; Frye S; Zhang Y; Xu YH; Lei QY; Guan KL; Zhao SM; Xiong Y Cancer Cell; 2011 Jan; 19(1):17-30. PubMed ID: 21251613 [TBL] [Abstract][Full Text] [Related]
49. Bioluminescent High-Throughput Succinate Detection Method for Monitoring the Activity of JMJC Histone Demethylases and Fe(II)/2-Oxoglutarate-Dependent Dioxygenases. Alves J; Vidugiris G; Goueli SA; Zegzouti H SLAS Discov; 2018 Mar; 23(3):242-254. PubMed ID: 29239273 [TBL] [Abstract][Full Text] [Related]
50. Evolution and conservation of JmjC domain proteins in the green lineage. Huang Y; Chen D; Liu C; Shen W; Ruan Y Mol Genet Genomics; 2016 Feb; 291(1):33-49. PubMed ID: 26152513 [TBL] [Abstract][Full Text] [Related]
51. Linking of 2-oxoglutarate and substrate binding sites enables potent and highly selective inhibition of JmjC histone demethylases. Woon EC; Tumber A; Kawamura A; Hillringhaus L; Ge W; Rose NR; Ma JH; Chan MC; Walport LJ; Che KH; Ng SS; Marsden BD; Oppermann U; McDonough MA; Schofield CJ Angew Chem Int Ed Engl; 2012 Feb; 51(7):1631-4. PubMed ID: 22241642 [No Abstract] [Full Text] [Related]
52. Purification of histone demethylases from HeLa cells. Tsukada Y; Zhang Y Methods; 2006 Dec; 40(4):318-26. PubMed ID: 17101443 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and Characterisation of Substrate-Based Peptides as Inhibitors of Histone Demethylase KDM4C. Nielsen SD; Leurs U; Bergner M; Barris SA; Devkota K; Meyer K; Iaria D; McCaughan J; Lohse B; Kristensen JL; Clausen RP Protein Pept Lett; 2016; 23(9):772-6. PubMed ID: 27295953 [TBL] [Abstract][Full Text] [Related]
54. The future therapeutic potential of histone demethylases: A critical analysis. Natoli G; Testa G; De Santa F Curr Opin Drug Discov Devel; 2009 Sep; 12(5):607-15. PubMed ID: 19736620 [TBL] [Abstract][Full Text] [Related]
55. Discovery of a potent and selective inhibitor of histone lysine demethylase KDM4D. Fang Z; Liu Y; Zhang R; Chen Q; Wang T; Yang W; Fan Y; Yu C; Xiang R; Yang S Eur J Med Chem; 2021 Nov; 223():113662. PubMed ID: 34237635 [TBL] [Abstract][Full Text] [Related]
56. The catalytic domains of all human KDM5 JmjC demethylases catalyse N-methyl arginine demethylation. Bonnici J; Oueini R; Salah E; Johansson C; Schofield CJ; Kawamura A FEBS Lett; 2023 Apr; 597(7):933-946. PubMed ID: 36700827 [TBL] [Abstract][Full Text] [Related]
57. Control of histone H3 lysine 9 (H3K9) methylation state via cooperative two-step demethylation by Jumonji domain containing 1A (JMJD1A) homodimer. Goda S; Isagawa T; Chikaoka Y; Kawamura T; Aburatani H J Biol Chem; 2013 Dec; 288(52):36948-56. PubMed ID: 24214985 [TBL] [Abstract][Full Text] [Related]
58. Crystal structure and functional analysis of JMJD5 indicate an alternate specificity and function. Del Rizzo PA; Krishnan S; Trievel RC Mol Cell Biol; 2012 Oct; 32(19):4044-52. PubMed ID: 22851697 [TBL] [Abstract][Full Text] [Related]